Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Halazy, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Halazy, S
      G-protein coupled receptors bivalent ligands and drug design

      EXPERT OPINION ON THERAPEUTIC PATENTS
    2. Dupuis, DS; Perez, M; Halazy, S; Colpaert, FC; Pauwels, PJ
      Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [S-35]GTP gamma S binding responses

      MOLECULAR BRAIN RESEARCH
    3. John, GW; Pauwels, PJ; Perez, M; Halazy, S; Le Grand, B; Verscheure, Y; Valentin, JP; Palmier, C; Wurch, T; Chopin, P; Marien, M; Kleven, MS; Koek, W; Assie, MB; Carilla-Durand, E; Tarayre, JP; Colpaert, FC
      F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. LAMOTHE M; PAUWELS PJ; LEBORGNE M; HALAZY S
      SYNTHESIS OF NEW BENZOTHIENYLPIPERAZINE DERIVATIVES AND THEIR CHARACTERIZATION AT BOTH 5HT(1A) AND 5HT(1B) RECEPTOR-SITES

      Medicinal chemistry research
    5. PEREZ M; PAUWELS PJ; FOURRIER C; CHOPIN P; VALENTIN JP; JOHN GW; MARIEN M; HALAZY S
      DIMERIZATION OF SUMATRIPTAN AS AN EFFICIENT WAY TO DESIGN A POTENT, CENTRALLY AND ORALLY-ACTIVE 5-HT1B AGONIST

      Bioorganic & medicinal chemistry letters
    6. GOTTELAND JP; LOUBAT C; PLANTY B; JUNQUERO D; DELHON A; HALAZY S
      SULFONAMIDE DERIVATIVES OF BENZYLAMINE BLOCK CHOLESTEROL-BIOSYNTHESISIN HEPG(2) CELLS - A NEW-TYPE OF POTENT SQUALENE EPOXIDASE INHIBITORS

      Bioorganic & medicinal chemistry letters
    7. PEREZ M; JORANDLEBRUN C; PAUWELS PJ; PALLARD I; HALAZY S
      DIMERS OF 5HT(1) LIGANDS PREFERENTIALLY BIND TO 5HT(1B 1D) RECEPTOR SUBTYPES/

      Bioorganic & medicinal chemistry letters
    8. Perez, M; Pauwels, PJ; Pallard-Sigogneau, I; Fourrier, C; Chopin, P; Palmier, C; Colovray, V; Halazy, S
      Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    9. JORANDLEBRUN C; VALOGNES D; HALAZY S
      USE OF TRIPHOSGENE FOR DIRECT PREPARATION OF CARBAMOYL CHLORIDES FROMTERTIARY BENZYLAMINES

      Synthetic communications
    10. PAUWELS PJ; DUPUIS DS; PEREZ M; HALAZY S
      DIMERIZATION OF 8-OH-DPAT INCREASES ACTIVITY AT SEROTONIN 5-HT1A RECEPTORS

      Naunyn-Schmiedeberg's archives of pharmacology
    11. JOHN GW; VERSCHEURE Y; INFANTI F; BEL L; PEREZ M; HALAZY S; CHOPIN P; MARIEN M; COLPAERT FC
      IN-VIVO PHARMACOLOGICAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY ANTIMIGRAINE 5-HT1B D RECEPTOR AGONIST/

      Naunyn-Schmiedeberg's archives of pharmacology
    12. JOHN GW; VALENTIN JP; LEGRAND B; BONNAFOUS R; PANISSIE A; VIE B; PEREZ M; HALAZY S; PAUWELS PJ; COLPAERT FC
      IN-VITRO VASCULAR AND NEURONAL ACTIONS OF F-11356, A NOVEL HIGH EFFICACY 5HT(1B D) RECEPTOR AGONIST, IN MODELS RELEVANT TO MIGRAINE/

      Naunyn-Schmiedeberg's archives of pharmacology
    13. PAUWELS PJ; PALMIER C; TARDIF S; WURCH T; PEREZ M; CARILLADURAND E; JOHN GW; HALAZY S; COLPAERT FC
      F-11356, A NEW 5-HT DERIVATIVE, WITH SELECTIVE, POTENT AND HIGH EFFICACY AGONIST PROPERTIES AT 5-HT1B D RECEPTORS/

      Naunyn-Schmiedeberg's archives of pharmacology
    14. HALAZY S; LAMOTHE M; JORANDLEBRUN C
      5-HT1B 1D ANTAGONISTS AND DEPRESSION

      Expert opinion on therapeutic patents
    15. GOTTELAND JP; DAX C; HALAZY S
      DESIGN AND SYNTHESIS OF NEW POTENTIAL PHOTOAFFINITY LABELS FOR MAMMALIAN SQUALENE EPOXIDASE

      Bioorganic & medicinal chemistry letters
    16. JORANDLEBRUN C; PAUWELS PJ; PALMIER C; CHOPIN P; MORET C; MARIEN M; HALAZY S
      ARYLPIPERAZIDE DERIVATIVES OF PHENYLPIPERAZINES AS A NEW CLASS OF POTENT AND SELECTIVE 5-HT1B RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    17. PEREZ M; AYERBE N; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS, BINDING-AFFINITY AND INTRINSIC ACTIVITY OF NEW ANILIDE DERIVATIVES OF SEROTONIN AT HUMAN 5-HT1D RECEPTORS

      European journal of medicinal chemistry
    18. JORANDLEBRUN C; PAUWELS PJ; PALMIER C; MORET C; CHOPIN P; PEREZ M; MARIEN M; HALAZY S
      5-HT1B RECEPTOR ANTAGONIST PROPERTIES OF NOVEL ARYLPIPERAZIDE DERIVATIVES OF 1-NAPHTHYLPIPERAZINE

      Journal of medicinal chemistry
    19. LAMOTHE M; PAUWELS PJ; BELLIARD K; SCHAMBEL P; HALAZY S
      DIFFERENTIATION BETWEEN PARTIAL AGONISTS AND NEUTRAL 5-HT1B ANTAGONISTS BY CHEMICAL MODULATION OF PYL]-4-HYDROXY-N-[4-(PYRIDIN-4-YL)PHENYL]BENZAMIDE (GR-55562)

      Journal of medicinal chemistry
    20. JUNQUERO D; OMS P; GOTTELAND JP; DEGRYSE AD; HALAZY S; DELHON A
      LIPID-REGULATING EFFECTS OF NEW CLASSES OF SQUALENE EPOXIDASE INHIBITORS

      Atherosclerosis
    21. PERRIN D; HALAZY S; HILL B
      INHIBITORS OF RAS FARNESYLATION - TOMORRO WS ANTICANCER AGENTS

      Bulletin du cancer
    22. PERRIN D; HALAZY S; HILL BT
      INHIBITORS OF THE RAS SIGNAL-TRANSDUCTION PATHWAY AS POTENTIAL ANTITUMOR AGENTS

      Journal of enzyme inhibition
    23. HALAZY S; GOTTELAND JP
      SQUALENE EPOXIDASE INHIBITORS

      Expert opinion on therapeutic patents
    24. GOTTELAND JP; JUNQUERO D; OMS P; DELHON A; HALAZY S
      COMPARATIVE-STUDY OF NEW AND KNOWN THIENYL DERIVATIVES OF ENE-YNE BENZYLAMINE AS MAMMALIAN SQUALENE EPOXIDASE INHIBITORS

      Medicinal chemistry research
    25. GOTTELAND JP; DELHON A; JUNQUERO D; OMS P; HALAZY S
      DESIGN AND SYNTHESIS OF NEW HYPOCHOLESTEROLEMIC ORGANOSILANES WITH ANTIOXIDANT PROPERTIES

      Bioorganic & medicinal chemistry letters
    26. NAVE JF; CASARA PJ; TAYLOR DL; TYMS AS; KENNY M; HALAZY S
      SYNTHESIS, ENZYMATIC PHOSPHORYLATION AND ANTIVIRAL ACTIVITY OF ACYCLIC DIENYL PHOSPHONATE DERIVATIVES OF GUANINE

      Bioorganic & medicinal chemistry letters
    27. LAMOTHE M; PERRIN D; BLOTIERES D; LEBORGNE M; GRAS S; BONNET D; HILL BT; HALAZY S
      INHIBITION OF FARNESYL-PROTEIN TRANSFERASE BY NEW FARNESYL PHOSPHONATE DERIVATIVES OF PHENYLALANINE

      Bioorganic & medicinal chemistry letters
    28. LAMOTHE M; PEREZ M; COLOVRAYGOTTELAND V; HALAZY S
      A SIMPLE ONE-POT PREPARATION OF N,N'-UNSYMMETRICAL UREAS FROM N-BOC PROTECTED PRIMARY ANILINES AND AMINES

      Synlett
    29. PEREZ M; POTIER P; HALAZY S
      SYNTHESIS OF ARYLPIPERAZINES VIA NUCLEOPHILIC AROMATIC-SUBSTITUTION OF (ETA(6)-FLUOROARENE)TRICARBONYLCHROMIUM COMPLEXES

      Tetrahedron letters
    30. HALAZY S; EHRHARD A; EGGENSPILLER A; BERGESGROSS V; DANZIN C
      FLUOROPHOSPHONATE DERIVATIVES OF N-9-BENZYLGUANINE AS POTENT, SLOW-BINDING MULTISUBSTRATE ANALOG INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE

      Tetrahedron
    31. GOTTELAND JP; GUILHEM MC; HALAZY S
      A CONVERGENT AND STRAIGHTFORWARD SYNTHETIC METHOD TO PREPARE DEAZA-ANALOGS OF SQUALENE EPOXIDASE INHIBITORS

      Synthetic communications
    32. HALAZY S; PEREZ M; FOURRIER C; PALLARD I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; BONNAFOUS R; MARTINEZ J
      SEROTONIN DIMERS - APPLICATION OF THE BIVALENT LIGAND APPROACH TO THEDESIGN OF NEW POTENT AND SELECTIVE 5-HT1B 1D AGONISTS/

      Journal of medicinal chemistry
    33. PEREZ M; PAUWELS P; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      5-O-CARBOXYMETHYL PIPERAZIDE DERIVATIVES OF SEROTONIN - A NEW CLASS OF POTENT AND SELECTIVE 5-HT1D RECEPTOR AGONISTS

      Bioorganic & medicinal chemistry letters
    34. GOTTELAND JP; HALAZY S
      AN EFFICIENT APPROACH TO THE SYNTHESIS OF A KEY PRECURSOR OF MAMMALIAN SQUALENE EPOXIDASE INHIBITORS USING A NEW METHOD FOR TRANSFORMING ARYL BROMIDES TO PHENOLS

      Synlett
    35. NAVE JF; TAYLOR D; TYMS S; KENNY M; EGGENSPILLER A; ESCHBACH A; DULWORTH J; BRENNAN T; PIRIOU F; HALAZY S
      SYNTHESIS, ANTIVIRAL ACTIVITY AND ENZYMATIC PHOSPHORYLATION OF 9-PHOSPHONOPENTENYL DERIVATIVES OF GUANINE

      Antiviral research
    36. PEREZ M; FOURRIER C; SIGOGNEAU I; PAUWELS PJ; PALMIER C; JOHN GW; VALENTIN JP; HALAZY S
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF ARYLPIPERAZIDE DERIVATIVES OF SEROTONIN - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    37. GOTTELAND JP; BRUNEL I; GENDRE F; DESIRE J; DELHON A; JUNQUERO D; OMS P; HALAZY S
      (ARYLOXY)METHYLSILANE DERIVATIVES AS NEW CHOLESTEROL-BIOSYNTHESIS INHIBITORS - SYNTHESIS AND HYPOCHOLESTEROLEMIC ACTIVITY OF A NEW CLASS OFSQUALENE EPOXIDASE INHIBITORS

      Journal of medicinal chemistry
    38. NAVE JF; ESCHBACH A; WOLFFKUGEL D; HALAZY S; BALZARINI J
      ENZYMATIC PHOSPHORYLATION AND PYROPHOSPHORYLATION OF 2',3'-DIDEOXYADENOSINE-5'-MONOPHOSPHATE, A KEY METABOLITE IN THE PATHWAY FOR ACTIVATION OF THE ANTI-HIV (HUMAN-IMMUNODEFICIENCY-VIRUS) AGENT 2',3'-DIDEOXYINOSINE

      Biochemical pharmacology
    39. WOLFFKUGEL D; HALAZY S
      STUDIES TOWARDS THE SYNTHESIS OF THE SATURATED AND UNSATURATED CARBOCYCLIC METHYLENE PHOSPHONATE ANALOGS OF DIDEOXYADENOSINE

      Nucleosides & nucleotides


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 14:17:46